S&P 500 Futures
(-0.77%) 5 068.25 points
Dow Jones Futures
(-0.27%) 38 574 points
Nasdaq Futures
(-1.37%) 17 423 points
Oil
(0.17%) $82.95
Gas
(-0.54%) $1.644
Gold
(-0.39%) $2 329.20
Silver
(-0.68%) $27.16
Platinum
(-0.51%) $911.10
USD/EUR
(-0.07%) $0.934
USD/NOK
(-0.05%) $10.98
USD/GBP
(-0.04%) $0.802
USD/RUB
(0.01%) $92.33

Realtime updates for Genetic Signatures Ltd [GSS.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated24 Apr 2024 @ 02:10

0.00% $ 0.680

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 02:10):

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa...

Stats
Today's Volume 75 859.00
Average Volume 122 301
Market Cap 126.81M
EPS $0 ( 2024-02-19 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.67
ATR14 $0 (0.00%)

Genetic Signatures Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Genetic Signatures Ltd Financials

Annual 2023
Revenue: $16.94M
Gross Profit: $-12.74M (-75.21 %)
EPS: $-0.0957
Q2 2024
Revenue: $3.60M
Gross Profit: $-9.44M (-262.04 %)
EPS: $-0.0729
Q4 2023
Revenue: $6.53M
Gross Profit: $-8.93M (-136.59 %)
EPS: $-0.0516
Q3 2022
Revenue: $5.28M
Gross Profit: $2.29M (43.43 %)
EPS: $-0.0264

Financial Reports:

No articles found.

Genetic Signatures Ltd

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators